HER2 Oncogenic Function Escapes EGFR Tyrosine Kinase Inhibitors via Activation of Alternative HER Receptors in Breast Cancer Cells
PLoS ONE (2008) - Comments

Anthony Kong, Véronique Calleja, Pierre Leboucher, Adrian Harris, Peter J. Parker, Banafshé Larijani